Efficacy of dupilumab and risk factors for dupilumab-induced hypereosinophilia in severe asthma: a preliminary study from China

Author:

Li You12,Deng Zhenan1,Wen Junjie1,Ou Changxing1,Cen Xiaomin1,Liao Yongkang1,Zhang Qingling1,Xie Jiaxing1

Affiliation:

1. Department of pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

2. Department of Pulmonary and Critical Care Medicine, Shenzhen Guangming District People’s Hospital, Shenzhen, China

Funder

National Natural Science Foundation of China

Zhongnanshan Medical Foudation of Guangdong Province

Guangzhou Science and Technology Plan Project and Zhongnanshan Medical Foudation of Guangdong Province

Science and Technology Innovation Project of Guangzhou Medical University

Undergraduate Innovation Ability Improvement Program of Guangzhou Medical University

Foundation of Featured Clinical Technique of Guangzhou

Construction Project of Guangzhou Demonstration Unit for Collaborative Treatment of Critical and Difficult Diseases with Traditional Chinese and Western Medicine,

and Science and Technology Program of Guangzhou

Publisher

Informa UK Limited

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3